Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

5.6%

2 terminated/withdrawn out of 36 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

80%

16 of 20 completed trials have results

Key Signals

9 recruiting16 with results

Enrollment Performance

Analytics

N/A
21(91.3%)
Phase 3
1(4.3%)
Phase 4
1(4.3%)
23Total
N/A(21)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (36)

Showing 20 of 36 trials
NCT07298473Not ApplicableRecruiting

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Role: lead

NCT07585968Not ApplicableNot Yet Recruiting

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

Role: lead

NCT07308847Not ApplicableRecruiting

Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)

Role: lead

NCT05227053Recruiting

STOP AF First Post-Approval Study

Role: lead

NCT05005949Active Not Recruiting

STOP Persistent AF PAS

Role: lead

NCT06578104Recruiting

PULSED AF Post-Approval Study

Role: lead

NCT05230524Terminated

DIAMOND AF Post-Approval Study

Role: lead

NCT06858306Active Not Recruiting

SPHERE Per-AF Post-Approval Study

Role: lead

NCT06703489Not ApplicableRecruiting

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

Role: lead

NCT04735016Active Not Recruiting

DiamondTemp Global Registry

Role: lead

NCT06393920Recruiting

PulseSelect™ PFA Global Registry

Role: lead

NCT07575828Not ApplicableNot Yet Recruiting

Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation

Role: lead

NCT01490814Not ApplicableCompleted

FIRE AND ICE: Comparative Study of Two Ablation Procedures in Patients With Atrial Fibrillation

Role: lead

NCT05144503Not ApplicableRecruiting

Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation

Role: lead

NCT05115214Not ApplicableRecruiting

Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation

Role: lead

NCT03643224Not ApplicableCompleted

DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

Role: lead

NCT06026345Recruiting

Affera Global Registry

Role: lead

NCT02752737Completed

Cryo Global Registry

Role: lead

NCT04210622Completed

An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System

Role: lead

NCT04211441Not ApplicableCompleted

Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias

Role: lead